Maravai LifeSciences Holdings, Inc. Class A Common Stock

MRVINASDAQUSD
6.25 USD
0.16 (2.50%)AT CLOSE (11:59 AM EDT)
5.75
0.50 (7.98%)
POST MARKET (AS OF 07:53 PM EDT)
Post Market
AS OF 07:53 PM EDT
5.75
0.50 (7.98%)
🔴Market: CLOSED

Maravai LifeSciences Holdings, Inc. Class A Common Stock (MRVI) is currently trading at $6.26. The stock presents a bearish profile across the board: technical indicators signal "Sell" and our fundamental models agree with a "Sell" rating. This is driven by a concerning Altman Z-Score in the distress zone, negative Return on Equity and a bullish Golden Cross on the moving averages. On valuation, MRVI trades roughly in line with sector averages — neither particularly cheap nor expensive.

Technical & fundamental data as of Aug 6, 2026.

Open?$6.42
High?$6.45
Low?$6.16
Prev. Close?$6.41
Volume?1.5M
Avg. Volume?2.9M
VWAP?$6.23
Rel. Volume?0.51x
Bid / Ask
Bid?$5.65 × 100
Ask?$5.80 × 1.0K
Spread?$0.15
Midpoint?$5.73
Valuation & Ratios
Market Cap?921.9M
Shares Out?147.5M
Float?117.9M
Float %?80.6%
P/E Ratio?N/A
P/B Ratio?4.36
EPS?-$0.71
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Maravai LifeSciences Holdings Inc is a life sciences company providing products and services to enable the development of drugs, therapeutics, vaccines and diagnostics, and to support research on human disease. Its product portfolio includes complex nucleic acids, custom enzymes and antibody-based solutions for therapeutic, vaccine, diagnostic and biopharmaceutical production applications. The Company operates through two segments: TriLink, which generates maximum revenue from North America and provides nucleic acid products and services including mRNA, oligonucleotides and related technologies; and Cygnus, which provides biologics safety testing products and services including host cell protein ELISA kits, impurity detection assays and related reagents and services.
Employees
416
Market Cap
945.5M
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2020-11-20
Address
10770 WATERIDGE CIRCLE SUITE 200
SAN DIEGO, CA 92121
Phone: (858) 546-0004
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)? Neutral(0/3)
Medium-Term (Wave)? Neutral(0/3)
Short-Term (Ripple)? Bearish(-3/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
23
Z-Score?
20
Momentum?
62
Short Sent.?
41
Piotroski F-Score?3/9Weak
Altman Z-Score?1.48Distress
Confidence?66%Moderate
Full Fundamental Analysis →
Short InterestElevated
Short % of Float?7.86%Elevated
Short Interest?9.3M
Days to Cover?3.0
Free Float117.9M
Avg Daily Volume3.1M
Settlement Date2026-07-15
Financial Health
Current Ratio?5.91Strong
Quick Ratio?4.96Strong
Cash Ratio?3.89Strong
Debt/Equity?1.28Moderate
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
75/100
P/E?
N/A
P/B?
Peers
100
S&P
41
4.36FAIR
P/S?
Peers
100
S&P
33
4.50FAIR
P/FCF?
N/A
EV/EBITDA?
S&P
97
-25.0CHEAP
EV/Sales?
Peers
100
S&P
36
5.02FAIR
Returns & Efficiency
ROE?
S&P
3
-49.4%WEAK
ROA?
S&P
3
-14.7%WEAK
Cash Flow & Enterprise
FCF?$-51869000
Enterprise Value?$1.0B
Fundamentals ratios updated end of day